Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 821

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 821
---
 |     | Section 6.8       |
| [***]                      |     | [***]             |
| Royalty Floor              |     | Section 7.4(c)(v) |
| Royalty Report             |     | Section 7.4(d)    |
| Royalty Term               |     | Section 7.4(b)    |
| Sanctioned Country         |     | Section 13.1(z)   |
| SDN List                   |     | Section 13.1(z)   |
| [***]                      |     | [***]             |
| Sell-Off Period            |     | Section 12.2(b)   |
| SEZ6                       |     | Recital A         |
| Signing Payment            |     | Section 7.1(a)    |
| Term                       |     | Section 11.1      |
| Third Party Claim          |     | Section 14.1      |
| WuXi Biologics             |     | Preamble          |
| WuXi Biologics Indemnitees |     | Section 14.1      |
| WuXi XDC                   |     | Section 2.3(a)    |

ARTICLE II GRANT OF LICENSE 2.1 Licenses. (a) Exclusive License. Subject to the terms and conditions of this Agreement, WuXi Biologics hereby grants to Aadi an exclusive (even as to WuXi Biologics and its Affiliates), royalty-bearing, transferrable (subject to Section 16.8) license, with the right to grant and authorize sublicenses through multiple tiers as provided in Section 2.2, under the Licensed IP, to Exploit Licensed ADCs and Licensed Products in the Field in the Territory. (b) License to WuXi Biologics to Perform Obligations. Subject to the terms and conditions of this Agreement, Aadi hereby grants to WuXi Biologics a non-exclusive,royalty-free license under the Licensed IP in the Field in the Territory as necessary for WuXi Biologics to perform its obligations for the benefit of Aadi under this Agreement. G-10

2.2 Sublicensing.

(a) Aadi shall have the right to grant and authorize sublicenses under the license set forth above in Section 2.1(a) without the
consent of WuXi Biologics to one or more Affiliates of Aadi or to Third Parties. Any sublicense by Aadi